1D8E
Zinc-depleted FTase complexed with K-RAS4B peptide substrate and FPP analog.
Summary for 1D8E
Entry DOI | 10.2210/pdb1d8e/pdb |
Related | 1d8d 1ft1 1ft2 |
Descriptor | FARNESYLTRANSFERASE (ALPHA SUBUNIT), FARNESYLTRANSFERASE (BETA SUBUNIT), K-RAS4B PEPTIDE SUBSTRATE, ... (6 entities in total) |
Functional Keywords | ftase, pft, pftase, farnesyltransferase, farnesyl transferase, caax, ras, cancer, transferase |
Biological source | Rattus norvegicus (Norway rat) More |
Cellular location | Cell membrane; Lipid-anchor; Cytoplasmic side: P01116 |
Total number of polymer chains | 3 |
Total formula weight | 94537.59 |
Authors | Long, S.B.,Casey, P.J.,Beese, L.S. (deposition date: 1999-10-22, release date: 2000-03-20, Last modification date: 2024-03-13) |
Primary citation | Long, S.B.,Casey, P.J.,Beese, L.S. The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures. Structure Fold.Des., 8:209-222, 2000 Cited by PubMed Abstract: The protein farnesyltransferase (FTase) catalyzes addition of the hydrophobic farnesyl isoprenoid to a cysteine residue fourth from the C terminus of several protein acceptors that are essential for cellular signal transduction such as Ras and Rho. This addition is necessary for the biological function of the modified proteins. The majority of Ras-related human cancers are associated with oncogenic variants of K-RasB, which is the highest affinity natural substrate of FTase. Inhibition of FTase causes regression of Ras-mediated tumors in animal models. PubMed: 10673434DOI: 10.1016/S0969-2126(00)00096-4 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3 Å) |
Structure validation
Download full validation report